Pure Advantage

Acceler8 Grape

F
N+ Score52
Joint & BoneServing: 22.5 Gram(s)Type: Other Combinations [A1325]

Pure Advantage Acceler8 Grape is a dietary supplement formulated to support joint and bone health. It contains vitamins, minerals, and amino acids like L-Glutamine and L-Arginine AKG. This product is intended for individuals seeking to maintain joint function and bone integrity.

About This Product

Acceler8 Grape by Pure Advantage is a joint & bone supplement containing 23 active ingredients. It has earned an N+ Score of 52/100 (Grade F).

Notable clinical-dose ingredients include Niacin, Vitamin B12, Vitamin C and 2 more.

N+ Score Breakdown

Ingredient Adequacy38/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency61/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Broad ingredient diversity exceeding category norms
  • +5 ingredient(s) at clinical dose levels
  • +Rich formula with 23 active ingredients

Weaknesses

  • −Several ingredients below clinically effective doses
  • −Missing several expected ingredients for its category

Ingredient Analysis (23 ingredients)

IngredientAmountDose Adequacy
Calories64.000 Calorie(s)N/A
Niacin30.000 mgOptimal
Vitamin B126.000 mcgOptimal
Vitamin C400.000 mgOptimal
Calcium150.000 mgUnder
Magnesium50.000 mgUnder
Total Carbohydrates13.000 Gram(s)N/A
Sugar8.000 Gram(s)N/A
Folic Acid200.000 mcgAdequate
Sodium55.000 mgN/A
Potassium300.000 mgUnder
L-Glutamine—N/A
Caffeine—N/A
Phosphorus40.000 mgUnder
Vitamin B11.500 mgOptimal
L-Tyrosine—N/A
Trimethylglycine—N/A
L-Glycine—N/A
Evodiamine—N/A
L-Arginine AKG—N/A
Proprietary NO Muscle Matrix Blend4000.000 mgN/A
L-Arginine DL Malate—N/A
L-Citrulline L-Malate—N/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.